Effective immunosuppressive management with belatacept and eculizumab in post-transplant aHUS due to a homozygous deletion of CFHR1/CFHR3 and the presence of CFH antibodies

Abstract. Atypical haemolytic uraemic syndrome (aHUS) may clinically present as acute renal graft failure resulting from excessive activation of the complement

Saved in:
Bibliographic Details
Main Authors: Münch, Johannes (Author) , Bachmann, Anette (Author) , Kirschfink, Michael (Author)
Format: Article (Journal)
Language:English
Published: 10 July 2017
In: Clinical kidney journal
Year: 2017, Volume: 10, Issue: 6, Pages: 742-746
ISSN:2048-8513
DOI:10.1093/ckj/sfx053
Online Access:Verlag, kostenfrei, Volltext: http://dx.doi.org/10.1093/ckj/sfx053
Verlag, kostenfrei, Volltext: https://academic.oup.com/ckj/article/10/6/742/3947937
Get full text
Author Notes:Johannes Münch, Anette Bachmann, Maik Grohmann, Christof Mayer, Michael Kirschfink, Tom H. Lindner, Carsten Bergmann and Jan Halbritter

MARC

LEADER 00000caa a2200000 c 4500
001 1580435513
003 DE-627
005 20220814233316.0
007 cr uuu---uuuuu
008 180828s2017 xx |||||o 00| ||eng c
024 7 |a 10.1093/ckj/sfx053  |2 doi 
035 |a (DE-627)1580435513 
035 |a (DE-576)510435513 
035 |a (DE-599)BSZ510435513 
035 |a (OCoLC)1341017737 
040 |a DE-627  |b ger  |c DE-627  |e rda 
041 |a eng 
084 |a 33  |2 sdnb 
100 1 |a Münch, Johannes  |d 1977-  |e VerfasserIn  |0 (DE-588)1133388043  |0 (DE-627)889249288  |0 (DE-576)489432360  |4 aut 
245 1 0 |a Effective immunosuppressive management with belatacept and eculizumab in post-transplant aHUS due to a homozygous deletion of CFHR1/CFHR3 and the presence of CFH antibodies  |c Johannes Münch, Anette Bachmann, Maik Grohmann, Christof Mayer, Michael Kirschfink, Tom H. Lindner, Carsten Bergmann and Jan Halbritter 
264 1 |c 10 July 2017 
300 |a 5 
336 |a Text  |b txt  |2 rdacontent 
337 |a Computermedien  |b c  |2 rdamedia 
338 |a Online-Ressource  |b cr  |2 rdacarrier 
500 |a Gesehen am 28.08.2018 
520 |a Abstract. Atypical haemolytic uraemic syndrome (aHUS) may clinically present as acute renal graft failure resulting from excessive activation of the complement 
700 1 |a Bachmann, Anette  |d 1970-  |e VerfasserIn  |0 (DE-588)123846390  |0 (DE-627)706449142  |0 (DE-576)173691021  |4 aut 
700 1 |a Kirschfink, Michael  |e VerfasserIn  |0 (DE-588)120927152  |0 (DE-627)080974457  |0 (DE-576)292452411  |4 aut 
773 0 8 |i Enthalten in  |t Clinical kidney journal  |d Oxford : Oxford Univ. Press, 2012  |g 10(2017), 6, Seite 742-746  |h Online-Ressource  |w (DE-627)689395191  |w (DE-600)2656786-6  |w (DE-576)363260714  |x 2048-8513  |7 nnas  |a Effective immunosuppressive management with belatacept and eculizumab in post-transplant aHUS due to a homozygous deletion of CFHR1/CFHR3 and the presence of CFH antibodies 
773 1 8 |g volume:10  |g year:2017  |g number:6  |g pages:742-746  |g extent:5  |a Effective immunosuppressive management with belatacept and eculizumab in post-transplant aHUS due to a homozygous deletion of CFHR1/CFHR3 and the presence of CFH antibodies 
856 4 0 |u http://dx.doi.org/10.1093/ckj/sfx053  |x Verlag  |x Resolving-System  |z kostenfrei  |3 Volltext 
856 4 0 |u https://academic.oup.com/ckj/article/10/6/742/3947937  |x Verlag  |z kostenfrei  |3 Volltext 
951 |a AR 
992 |a 20180828 
993 |a Article 
994 |a 2017 
998 |g 120927152  |a Kirschfink, Michael  |m 120927152:Kirschfink, Michael  |d 910000  |d 911600  |e 910000PK120927152  |e 911600PK120927152  |k 0/910000/  |k 1/910000/911600/  |p 5 
999 |a KXP-PPN1580435513  |e 3024029656 
BIB |a Y 
SER |a journal 
JSO |a {"recId":"1580435513","language":["eng"],"type":{"media":"Online-Ressource","bibl":"article-journal"},"note":["Gesehen am 28.08.2018"],"person":[{"roleDisplay":"VerfasserIn","display":"Münch, Johannes","role":"aut","family":"Münch","given":"Johannes"},{"family":"Bachmann","given":"Anette","display":"Bachmann, Anette","roleDisplay":"VerfasserIn","role":"aut"},{"roleDisplay":"VerfasserIn","display":"Kirschfink, Michael","role":"aut","family":"Kirschfink","given":"Michael"}],"title":[{"title_sort":"Effective immunosuppressive management with belatacept and eculizumab in post-transplant aHUS due to a homozygous deletion of CFHR1/CFHR3 and the presence of CFH antibodies","title":"Effective immunosuppressive management with belatacept and eculizumab in post-transplant aHUS due to a homozygous deletion of CFHR1/CFHR3 and the presence of CFH antibodies"}],"relHost":[{"title":[{"title":"Clinical kidney journal","subtitle":"CKJ","title_sort":"Clinical kidney journal"}],"pubHistory":["5.2012 -"],"titleAlt":[{"title":"Clin Kidney J"},{"title":"CKJ"}],"part":{"text":"10(2017), 6, Seite 742-746","volume":"10","extent":"5","year":"2017","issue":"6","pages":"742-746"},"type":{"media":"Online-Ressource","bibl":"periodical"},"disp":"Effective immunosuppressive management with belatacept and eculizumab in post-transplant aHUS due to a homozygous deletion of CFHR1/CFHR3 and the presence of CFH antibodiesClinical kidney journal","note":["Gesehen am 27.05.2020"],"language":["eng"],"recId":"689395191","origin":[{"dateIssuedKey":"2012","publisher":"Oxford Univ. Press","dateIssuedDisp":"2012-","publisherPlace":"Oxford"}],"id":{"issn":["2048-8513"],"eki":["689395191"],"zdb":["2656786-6"]},"physDesc":[{"extent":"Online-Ressource"}]}],"physDesc":[{"extent":"5 S."}],"name":{"displayForm":["Johannes Münch, Anette Bachmann, Maik Grohmann, Christof Mayer, Michael Kirschfink, Tom H. Lindner, Carsten Bergmann and Jan Halbritter"]},"id":{"doi":["10.1093/ckj/sfx053"],"eki":["1580435513"]},"origin":[{"dateIssuedDisp":"10 July 2017","dateIssuedKey":"2017"}]} 
SRT |a MUENCHJOHAEFFECTIVEI1020